Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dr Roger Pomerantz joins Merck

This article was originally published in Scrip

Executive Summary

Merck & Co has named Dr Roger Pomerantz senior vice-president of Merck Research Laboratories and infectious diseases franchise head. He will oversee Merck's global scientific strategy across drug discovery and development for infectious diseases, including all antiviral, antibacterial, antifungal and antiparasitic agents. Dr Pomerantz has spent the past five years at Johnson & Johnson, where he most recently served as global head of infectious diseases and president of Peninsula Pharmaceuticals, a subsidiary of J&J that is focused on antibacterial research. Since 2005, he was also president of J&J's Tibotec Pharmaceuticals subsidiary, which is focused on antiviral and tuberculosis R&D.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts